Clinical Trials Directory

Trials / Completed

CompletedNCT04697537

Ultrasound-guided Regional Anesthesia vs Local Infiltration Anesthesia With Dexmedetomidine and Ropivacaine

Dexmedetomidine as Adjunct Medication to Local Infiltration Anesthesia (LIA) vs Ultrasound-Guided Regional Anesthesia (USRA) in Regard to Patients' Need for Opioids, Wellbeing, Satisfaction, and Knee Functionality in Knee-endoprosthetics

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid need the first 48 hours after the total knee replacement operation.

Detailed description

Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid need the first 48 hours after the total knee replacement operation. Secondary objectives are: Pain assesment, Pain medication necessary, functionality of the prothesis, satisfaction, wellbeing, postoperative discomforts, complications (delirium, allergic reactions, cardiopulmonary decompensation), procedure specific time.

Conditions

Interventions

TypeNameDescription
DRUGUltrasound guided regional anesthesiaApplied perineurally preoperatively ultrasound guided regional anesthesia
DRUGLocal infiltration analgesiaApplied in the wound intraoperatively from the orthopedics

Timeline

Start date
2021-02-01
Primary completion
2021-04-09
Completion
2021-04-09
First posted
2021-01-06
Last updated
2021-04-14

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04697537. Inclusion in this directory is not an endorsement.